Skip to main content

On first day of trading, Finch Therapeutics raises $128M in upsized IPO

Finch Therapeutics, the Somerville startup founded in 2014 to address a wide variety of diseases with microbiome treatments, has raised $128 million in its first day on the Nasdaq.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.